Type-2 diabetes and cognitive function in a non-demented population

Acta Neurologica Scandinavica

Volumn 100, Issue 2, 1999, Pages 97-101

  Vanhanen, M ^a   Kuusisto, J ^a   Koivisto, K ^a   Mykkanen L ^a   Helkala, E L ^a   Hanninen T ^b   Riekkinen, P ^a   Soininen, H ^a   Laakso, M ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Aging; Dementia; Diabetes mellitus; Epidemiology hyperinsulinemia; Neuropsychological tests; Non insulin dependent

Indexed keywords

AGED; AMNESIA; ARTICLE; COGNITIVE DEFECT; DEMENTIA; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; VERBAL BEHAVIOR;

EID: 0032769625     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1999.tb01045.x     Document Type: Article

References (24)

1. STRACHAN MWJ, DEARY IJ, EWING FME, FRIER BM. Is type II diabetes associated with an increased risk of cognitive dysfunction? Diabetes Care 1997;20:438-45.
2. OTT A, STOLK RP, HOFMAN A, VAN HARSKAMP F, GROBBEE DE, BRETELER MMB. Association of diabetes mellitus and dementia: the Rotterdam study. Diabetologia 1996;39:1392-7.
3. KUUSISTO J, KOIVISTO K, MYKKäNEN L etal. Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotypc: cross sectional population based study. Br Mcd J 1997;315:1045-9.
4. LEIBSON CL, ROCCA WA, HANSON VA etal. Risk of dementia among persons with diabetes mcllitus. Am J Epidemiol 1997;145:301-8.
5. YOSHITAKE T, KIYOIIARA Y, KATO I etal. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: The Hisayama study. Neurology 1995;45:1161-8.
6. VANUUIJIN CM. Epidemiology of the dementias: recent developments and new approaches. J Neurol Neurosurg Psychiatry 1996;60:478-88.
7. KUUSISTO J, KOIVISTO K, MYKKäNEN L etal. Essential hypertension and cognitive function. The role of hyperinsulinemia. Hypertension 1993;22:771-9.
8. KALMIJN S, FESKENS EJM, LAUNER LJ, STIJNEN T, KROMHOUT D. Glucose intolerance, hyperinsulinaemia and cognitive function in a general population of elderly men. Diabetologia I995;38:1096-102.
9. VANHANEN M, KOIVISTO K, KARJALAINEN L etal. Risk for non-insulin-dependent diabetes in the normoglycemic elderly is associated with impaired cognitive function. Neuroreport 1997;8:1527-30.
10. VANHANEN M, KOIVISTO K, KUUSISTO J etal. Cognitive function in an elderly population with persistent impaired glucose tolerance. Diabetes Care 1998;21:398J02.
11. MYKKäNEN L, LAAKSO M, UUSITUPA M, PYöRäLä K. Prevalence of diabetes and impaired glucose tolerance in elderly subjects and their association with obesity and family history of diabetes. Diabetes Care 1990;13:1099-105.
12. AMERICAN PSYCHIATRIC ASSOCIATION. Diagnostic and Statistical Manual of Mental Disorder (DSM-III-R). 3rd rev ed. Washington, DC: American Psychiatric Association, 1987.
13. WORLD HEALTH ORGANIZATION. WHO Study Group on Diabetes Mellitus. Technical Report. Series 727. Geneva: World Health Organization, 1985.
14. REAVEN GM, THOMPSON LW, NAIIUM D, HASKINS E. Relationship between hyperglycemia and cognitive function in older NIDDM patients. Diabetes Care 1990;13:16-21.
15. LOWE LP, TRANEL D, WALLACE RB, WELTY TK. Type II diabetes and cognitive function: a population-based study of native Americans. Diabetes Care 1994;17:891-6.
16. PERLMUTER LC, HAKAMI MK, HODGSON-HARRINGTON C etal. Decreased cognitive function in aging non-insulindependent diabetic patients. Am J Med 1984;77:1043-8.
17. JAGUSCII W, CRAMON DYV, RENNER R, HEPP KD. Cognitive function and metabolic state in elderly diabetic patients. Diabetes Nutr Metab 1992;5:265-74.
18. MATTLAR CE, FALCK B, RöNNEMAA T, HYYPPä MT. Neuropsychological cognitive performance of patients with type-2 diabetes. Scand J Rehabil Med 1985;17:101-5.
19. HELKALA EL, NISKANEN L, VIINAMAKI H, PARTAKEN J, UUSITUPA M. Short-term and long-term memory in elderly patients with NIDDM. Diabetes Care 1995;18:681-5.
20. Tovi J, SVANBORG E, NILSSON B-Y, ENGFELDT P. Diabetic neuropathy in elderly type 2 diabetic patients: effects of insulin treatment. Acta Neurol Scand 1998;98:436-53.
21. DEY J, MISRA A, DESAI NG, MAHAPATRA AK, PADMA MV. Cognitive function in younger type-2 diabetes. Diabetes Care 1997;20:32-5.
22. VANHANEN M, KARHU J, KOIVISTO K etal. ERPs reveal deficits in automatic cerebral stimulus processing in patients with NIDDM. Neuroreport 1996;7:2767-71.
23. CRAFT S, PESKIND E, SCHWARTZ MW, SCHELLENBERG GD, RASKIND M, PORTE D. Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype. Neurology 1998;50:164-8.
24. VANHANEN M, SOININEN H. Glucose intolerance, cognitive impairment and Alzheimer's disease. Curr Opin Neurol 1998;11:673-7.